Neuroone Medical Technologies (NMTC) Other Non-Current Liabilities (2016 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Other Non-Current Liabilities came in at $303805.0 in Q2 2026, down 70.81% on a YoY basis from $1.0 million in Q2 2025, and down 57.18% quarter-over-quarter from $709507.0 in Q1 2026.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Other Non-Current Liabilities for 9 consecutive years, with $303805.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Liabilities fell 70.81% year-over-year to $303805.0; the trailing twelve-month figure through Jun 2026 stood at $303805.0 (down 70.81% YoY), and the FY2025 full-year result was $1.3 million, down 40.81% from the prior year.
- Other Non-Current Liabilities slipped to $303805.0 in Q2 2026 per NMTC's latest filing, from $709507.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.1 million in Q3 2024 and bottomed at $303805.0 in Q2 2026.
- Historically, Other Non-Current Liabilities has averaged $1.2 million across 3 years, with a median of $1.2 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Liabilities tumbled 40.81% in 2025, then slumped 70.81% in 2026.
- Over 3 years, Other Non-Current Liabilities stood at $1.8 million in 2024, then sank by 53.92% to $806859.0 in 2025, then slumped by 62.35% to $303805.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $303805.0, $709507.0, and $806859.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 14.10 Mn | 12.05 Mn | 1.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 303,805.00 |
| Mar 31, 2026 | 709,507.00 |
| Dec 31, 2025 | 806,859.00 |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1.75 Mn |
| Sep 30, 2024 | 2.14 Mn |
| Mar 31, 2021 | 83,333.00 |
| Dec 31, 2020 | 83,333.00 |
| Sep 30, 2020 | 1.01 Mn |
| Jun 30, 2020 | 6.73 Mn |
| Mar 31, 2020 | 4.92 Mn |
| Dec 31, 2019 | 5.19 Mn |
| Jun 30, 2019 | 117,550.00 |
| Dec 31, 2018 | 1.14 Mn |
| Sep 30, 2018 | 1.13 Mn |
| Jun 30, 2018 | 188,000.00 |
| Mar 31, 2018 | 1.63 Mn |
| Dec 31, 2017 | 1.38 Mn |